Tag: Stem Cells
World-first cell trial raises concerns
The $1 million price tag for a trial injecting nose cells into spinal-injury patients would be better spent helping people live with their disabilities,...
Research shows regenerative benefit of MultiStem after spinal cord injury
Case Western Reserve University School of Medicine and Athersys, Inc. announced a joint scientific study on spinal cord injury will be published today in...
Stem cell research breaks new ground in 2010
WASHINGTON : Two US companies this year broke new ground by winning regulatory approval to start the first experiments using embryonic stem cells on...
Working2Walk 2010, Frank Reynolds
Changing the Face of Neuroscience: Are Stem Cells Really Required to Heal a Spinal Cord Injury?
Quadriplegic Donkey Walks Again with Adult Stem Cells
Eli the donkey provides another example from the animal world of the success of adult stem cells. On May 13, 2010 Eli was attacked...
StemCells wins approval to initiate Phase I/II spinal cord injury trial
StemCells, Inc. has received authorization from Swissmedic, the Swiss regulatory agency for therapeutic products, to initiate a Phase I/II clinical trial in Switzerland of...
Paralyzed monkeys walk again after iPS stem cell transplant treatment
Paralyzed marmoset monkeys are walking again after a Japanese research team transplanted induced pluripotent stem cells (iPS cells) into the animals' spines -- the...
Experiments Suggest Possible New Approach to Stem Cell Therapy for Spinal Cord Injury
Using Chitosan Channels to Guide Stem Cell Growth Could Be Promising Technique, Reports Neurosurgery
Newswise — Initial experiments suggest a possible new approach to stem...
Quadriplegic donkey walks again Stem cells aid recovery from spinal-cord injury
Eli the donkey’s recovery from incomplete quadriplegia could be the most important breakthrough in traumatic spinal-cord injuries and for the stem-cell treatment that restored...
StemCells plans chronic spinal cord injury trial
(Reuters) - StemCells Inc has filed for Swiss regulatory approval for the first clinical trial of its nerve stem cells in patients with spinal...
